Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Sinusway- a revolutionary single-use endoscope device for treatment of severe sinuses infection (Sinusitis)

Project description

An innovative endoscope for sinusitis diagnosis

Sinusitis is a severe infection of the cavities around the nasal passages and affects millions of people worldwide. If left untreated, there is a risk the infection will spread to other parts of the body, causing significant complications. To assist physicians in sinusitis diagnosis, the EU-funded Sinusway has developed a novel, lightweight, single-use endoscope that can turn inside the lumens of the cavity reaching the majority of the sinus area. The endoscope design and material allow the physician to have full control over the direction of the endoscope, facilitating correct diagnosis.

Objective

Rhinosinusitis (RS) (better known as sinusitis) is a severe infection caused when the tiny air pockets around the bones of the nose are filled with germs or fluids. Sinusitis affects more than 80 million people in Europe and 803 million around the world, making it one of the most common health problems worldwide. Sinusitis sufferers carry a huge burden of symptoms, including challenging breathing, headaches, facial pain, nasal congestions, fever and disrupted sleep all of which drastically affects their quality of life. Since thin sinus walls share a border with the surrounding tissue, sinus infection can spread beyond the border of sinuses and cause major complications to eyes, brain and even cause asthma and bone infections. Hence, proper diagnosis and management of sinusitis is essential to prevent the risk of complications. However, current drawbacks of tools available to physicians make diagnosis and management of sinusitis very difficult. Sinusway is a novel lightweight single use endoscope for patients suffering from sinusitis. Sinusway is the first one that allows the tip of the endoscope to turn sharply into lumens in the sinus and then advance in the direction of the angulation which was set, beyond the point of angulation and independently from it. This allows to reach more than 90% of the sinus area. Using an intuitive easy-to-use ergonomics, ENT physicians have full control over the direction of the advancement of the endoscope, without the need of the support from the anatomy to do so. As such, Sinusway represents a revolutionary solution to a global market expected to grow to €20.86 billion by 2022.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Coordinator

3NT MEDICAL LTD
Net EU contribution
€ 50 000,00
Address
22 HAMELACHA, BUILDING 3, ENTRANCE B
4809169 ROSH HAAYIN
Israel

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00
My booklet 0 0